ACRX - AcelRx Pharmaceuticals Stock Trading

AcelRx Pharmaceuticals (NASDAQ: ACRX ) provides an update on its business and DSUVIA launch metrics. More news on: AcelRx Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, Read more ...

REDWOOD CITY, Calif. , Jan. 13, 2020 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in healthcare institutions, today provided an update on its ...

I have covered AcelRx Pharmaceuticals ( ACRX ) previously, so investors should view this as an update to my earlier article on the company. In this article I will focus on the prospects of DSUVIA and Zalviso as a product – I believe the market potential is still underestimated...